Favipiravir works! Preliminary Clinical Studies Suggest Positive Effects on COVID-19 Patients

Since the outbreak of COVID-19, people around the globe have been eagerly awaiting a real breakthrough on its treatment. Fortunately, a silver lining seems finally to be showing up. The virus clearance rate is a well-established golden standard assessing the … Read more…

First Ever Multiplexed Serological SARS-CoV-2 Assay Released for Use in Surveillance Studies

Quansys Biosciences (Logan, UT, USA), a developer of multiplex immunoassays, has released its SARS-CoV-2 Human IgG(4- plex) enzyme-linked immunosorbent assay… COVID-19 | HospiMedica International SPECIAL NEWS BULLETIN: Click today to request your free ACRX discount prescription card and save up … Read more…

NIH’s NIAID initiating dose evaluation studies in animal models of Pluristem’s PLX-R18 in the treatment of acute radiation syndrome

Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, has announced that the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Aid / Disasters News From Medical News Today BEST DEAL UPDATE: SPECIAL … Read more…